These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 18406575)

  • 1. Clinical usefulness of tissue Doppler imaging in patients with mild to moderate aortic stenosis: a substudy of the aortic stenosis progression observation measuring effects of rosuvastatin study.
    Jassal DS; Tam JW; Dumesnil JG; Giannoccaro PJ; Jue J; Pandey AS; Joyner CD; Teo KK; Chan KL
    J Am Soc Echocardiogr; 2008 Sep; 21(9):1023-7. PubMed ID: 18406575
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluating the effectiveness of rosuvastatin in preventing the progression of diastolic dysfunction in aortic stenosis: A substudy of the aortic stenosis progression observation measuring effects of rosuvastatin (ASTRONOMER) study.
    Jassal DS; Bhagirath KM; Karlstedt E; Zeglinski M; Dumesnil JG; Teo KK; Tam JW; Chan KL
    Cardiovasc Ultrasound; 2011 Feb; 9(1):5. PubMed ID: 21299902
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rosuvastatin slows the development of diastolic dysfunction in calcific aortic stenosis.
    Moura LM; Ramos SF; Kristensen SD; Pinto FJ; Barros IM; Rocha-Gonçalves F
    J Heart Valve Dis; 2012 Jul; 21(4):463-72. PubMed ID: 22953672
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of rosuvastatin on progression of stenosis in adult patients with congenital aortic stenosis (PROCAS Trial).
    van der Linde D; Yap SC; van Dijk AP; Budts W; Pieper PG; van der Burgh PH; Mulder BJ; Witsenburg M; Cuypers JA; Lindemans J; Takkenberg JJ; Roos-Hesselink JW
    Am J Cardiol; 2011 Jul; 108(2):265-71. PubMed ID: 21565321
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostication of valvular aortic stenosis using tissue Doppler echocardiography: underappreciated importance of late diastolic mitral annular velocity.
    Poh KK; Chan MY; Yang H; Yong QW; Chan YH; Ling LH
    J Am Soc Echocardiogr; 2008 May; 21(5):475-81. PubMed ID: 17928192
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rationale, design, and baseline characteristics of a randomized trial to assess the effect of cholesterol lowering on the progression of aortic stenosis: the Aortic Stenosis Progression Observation: Measuring Effects of Rosuvastatin (ASTRONOMER) trial.
    Chan KL; Teo K; Tam J; Dumesnil JG;
    Am Heart J; 2007 Jun; 153(6):925-31. PubMed ID: 17540192
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rosuvastatin affecting aortic valve endothelium to slow the progression of aortic stenosis.
    Moura LM; Ramos SF; Zamorano JL; Barros IM; Azevedo LF; Rocha-Gonçalves F; Rajamannan NM
    J Am Coll Cardiol; 2007 Feb; 49(5):554-61. PubMed ID: 17276178
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tissue Doppler imaging in patients with moderate to severe aortic valve stenosis: clinical usefulness and diagnostic accuracy.
    Bruch C; Stypmann J; Grude M; Gradaus R; Breithardt G; Wichter T
    Am Heart J; 2004 Oct; 148(4):696-702. PubMed ID: 15459603
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tissue Doppler imaging in patients with advanced heart failure: relation to functional class and prognosis.
    Hamdan A; Shapira Y; Bengal T; Mansur M; Vaturi M; Sulkes J; Battler A; Sagie A
    J Heart Lung Transplant; 2006 Feb; 25(2):214-8. PubMed ID: 16446223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Left ventricular systolic and diastolic function in asymptomatic patients with moderate aortic stenosis.
    Steine K; Rossebø AB; Stugaard M; Pedersen TR
    Am J Cardiol; 2008 Oct; 102(7):897-901. PubMed ID: 18805118
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tissue Velocities and Myocardial Deformation in Asymptomatic and Symptomatic Aortic Stenosis.
    Carstensen HG; Larsen LH; Hassager C; Kofoed KF; Dalsgaard M; Kristensen CB; Jensen JS; Mogelvang R
    J Am Soc Echocardiogr; 2015 Aug; 28(8):969-80. PubMed ID: 25944424
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin resistance and LVH progression in patients with calcific aortic stenosis: a substudy of the ASTRONOMER trial.
    Capoulade R; Clavel MA; Dumesnil JG; Chan KL; Teo KK; Tam JW; Côté N; Mathieu P; Després JP; Pibarot P;
    JACC Cardiovasc Imaging; 2013 Feb; 6(2):165-74. PubMed ID: 23489530
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early detection of left ventricular dysfunction by Doppler tissue imaging and N-terminal pro-B-type natriuretic peptide in patients with symptomatic severe aortic stenosis.
    Galema TW; Yap SC; Geleijnse ML; van Thiel RJ; Lindemans J; ten Cate FJ; Roos-Hesselink JW; Bogers AJ; Simoons ML
    J Am Soc Echocardiogr; 2008 Mar; 21(3):257-61. PubMed ID: 17628412
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Left ventricular filling pressure estimation at rest and during exercise in patients with severe aortic valve stenosis: comparison of echocardiographic and invasive measurements.
    Dalsgaard M; Kjaergaard J; Pecini R; Iversen KK; Køber L; Moller JE; Grande P; Clemmensen P; Hassager C
    J Am Soc Echocardiogr; 2009 Apr; 22(4):343-9. PubMed ID: 19269785
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Left ventricular function in patients with chronic kidney disease evaluated by colour tissue Doppler velocity imaging.
    Hayashi SY; Rohani M; Lindholm B; Brodin LA; Lind B; Barany P; Alvestrand A; Seeberger A
    Nephrol Dial Transplant; 2006 Jan; 21(1):125-32. PubMed ID: 16221719
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impaired myocardial function in hypertrophic cardiomyopathy.
    Saccheri MC; Cianciulli TF; Lax JA; Guerra JE; Redruello HJ; Weich Glogier FL; Gagliardi JA; Dorelle AN; Prezioso HA; Vidal LA
    Echocardiography; 2009 Jul; 26(6):657-64. PubMed ID: 19594814
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of Lipid lowering with rosuvastatin on progression of aortic stenosis: results of the aortic stenosis progression observation: measuring effects of rosuvastatin (ASTRONOMER) trial.
    Chan KL; Teo K; Dumesnil JG; Ni A; Tam J;
    Circulation; 2010 Jan; 121(2):306-14. PubMed ID: 20048204
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of Bicuspid aortic valve morphology and aortic root dimensions: a substudy of the aortic stenosis progression observation measuring effects of rosuvastatin (ASTRONOMER) study.
    Jassal DS; Bhagirath KM; Tam JW; Sochowski RA; Dumesnil JG; Giannoccaro PJ; Jue J; Pandey AS; Joyner CD; Teo KK; Chan KL
    Echocardiography; 2010 Feb; 27(2):174-9. PubMed ID: 19725842
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early impairment of left ventricular function in hypercholesterolemia and its reversibility after short term treatment with rosuvastatin A preliminary echocardiographic study.
    Talini E; Di Bello V; Bianchi C; Palagi C; Delle Donne MG; Penno G; Nardi C; Canale ML; Del Prato S; Mariani M; Miccoli R
    Atherosclerosis; 2008 Mar; 197(1):346-54. PubMed ID: 17631295
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of maintenance recombinant human erythropoietin therapy on ambulatory blood pressure recordings: conventional, Doppler, and tissue Doppler echocardiographic parameters.
    Kirkpantur A; Kahraman S; Yilmaz R; Arici M; Altun B; Erdem Y; Yasavul U; Turgan C
    Artif Organs; 2005 Dec; 29(12):965-72. PubMed ID: 16305652
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.